2 "Individuals" Shrouded in Mystery Here, this

New Post Public Reply Private Reply Replies (0) Message Board
biloxiblues
1,038



2 "Individuals" Shrouded in Mystery


Here, this is sort of an addendum to the previous article: The Manifestation of Truth Delivers a Tried & True and an Expected Resultant Outcome.

https://www.reddit.com/r/LeronLimab_Times/com...;context=3

This addendum will attempt to show how important the contribution of David Welch is and how important Sidley Austin's contribution is. That the contributions of these two "individuals" can not be underestimated.

Sidley Austin is a law firm representing CytoDyn in the Arbitration against Amarex; Mark D. Hopson | People | Sidley Austin LLP

while David Welch has massive investments in CYDY who is also the founder of 4-Good Ventures. https://www.4-good.com/ventures-healthcare-filter

Consider the following about these "individuals" and their contribution towards furthering the cause of CytoDyn:

These "individuals" are witnesses. They have seen, experienced and appreciated the power of this molecule in one way or another. David Welch has recognized that the power of Leronlimab is without equal and it has led him to become as heavily invested in CytoDyn as he currently is, and to provide that $6.5M bond in confidence because at worst, he would receive the rights to the molecule himself and build it back on his own. That's the kind of conviction this individual has because he has seen and experienced what it can do. His company of 4-Good Ventures is massively invested. Sidley Austin is a witness to the crimes committed against the company through all the hard and soft evidence they have uncovered. Who is paying this law firm? I have found no evidence that CytoDyn is paying them? Are they doing this for the pay out at the end? There is a powerful motivation for Sidley Austin to take on Amarex in this Arbitration and they are showing strong conviction.

It is on the evidence of two or three witnesses a matter shall be confirmed. Deuteronomy 19:15.

Every fact is to be confirmed by the testimony of two or three witnesses. 2 Corinthians 13:1

With Mr. Welch providing the $6.5 million bond, he has testified towards the validity of Leronlimab. He has placed great trust in the molecule, and in the law firm that represents CytoDyn and the molecule. He knew however, that for whatever reason, if that money was necessary in the end to pay Amarex, then, he would have received rights to the molecule with which, he would then go on to develop it. Today, things have changed and CytoDyn will not lose the patent rights to the molecule even if it is decided that Amarex be paid.

With all their hard work of Discovery over the past year, Sidley Austin has become privy to information which shall reveal the collusion and sabotage executed upon CytoDyn. Sidley Austin has discovered and uncovered certain information that unveils the heavy and weighted cover up of the collusive activity between Amarex and Big Pharma. Sidley Austin obtained and has in their possession, certain information on Amarex and 13D which proves collusion as well as sabotage. They have information on Big Pharma, Big Money and Big Media. They also have information on the FDA. They know what happened. Sidley Austin has the authority to interpret law.

Both of these "individuals" are the perfect candidates that the world could offer who could witness the strength and the power of Leronlimab, one witness in the clinical sense, on how well it performs in the field and one testifying against the sabotage and collusion inflicted upon it in the court room. These "individuals" are utterly massive, completely different from you and I; these individuals are truly massive in their own way, both being heavy hitters of their own kind who can pull in swarms of funding when necessary, and when they speak, like EF Hutton, people shall listen. But, so far, neither has spoken with their mouths, not to the public at least. Neither has said a word. But their actions have spoken volumes. They wait to speak. They wait for their win. They wait for Leronlimab's win. Now wait, the time approaches, when their mouths shall open and their words on behalf of Leronlimab and CytoDyn and upon the injustice which was executed upon this company and its molecule. They will speak also on how treacherous were all the lies and what harm these lies did to humanity as a result of these lies.

When these "individuals" decide to speak, much will be revealed. The very reason Mr. Welch put up $6.5M as surety for the bond. The precise reason why Sidley Austin is waging this arbitrage case against Amarex on behalf of CytoDyn with no promise of payment. The exact means by which Sidley Austin actually became involved and to what depths or to what extent did the Perpetrators go to sabotage CytoDyn and what their motivations and intentions were exactly. So these individuals will have the answers, but when will they speak? and to who will they speak? Well to the shareholders of course and to the world so as to draw them nigh.

We know that Mr. Welch is a huge shareholder who owns and runs a large venture capital company, but as far as I know, Sidley Austin is not a share holder per say. So then, what is Sidley Austin's interest in CytoDyn? Surely Sidley Austin believes that they have a future with CytoDyn in one way or another and I believe that too. Partnership maybe, a share in the profits, or becoming the law firm for CytoDyn? Both David Welch and Sidley Austin are trusted by all of CytoDyn's shareholders for their sheer actions in favor of the company. David Welch has put great faith in Sidley Austin when he put up that $6.5M bond. David Welch and Sidley Austin have the authority and shall stand up together in defense of CytoDyn and in offense against Amarex.

These individuals together shall stand up together against Amarex. And against anyone else who may be dragged into the case who colluded with Amarex. These "individuals" shall speak and make their arguments heard. They will demand justice for all the wrongs perpetrated against CytoDyn, justice for CytoDyn, justice for the share holders, justice for the patients, justice to rule for a fair recompense. There won't be anything left of Amarex, once the dust settles.

To me, it is clear that these individuals have the foresight to see Leronlimab's future. They are able to see what Leronlimab will do for us all and thus, they stand in confidence today, on its side, on its behalf. With their work in this Arbitration and with its successful outcome, these "individuals" help immensely in getting Leronlimab approved and distributed to market and they set a precedent in this case by installing a protection barrier surrounding CytoDyn thereby rendering Lerolimab untouchable by these Perpetrators into the coming years. In addition, these "individuals" shall stand along side with CytoDyn and shall help it to get Leronlimab approved for multiple indications as testified by the work they performed in this case. They shall feed CytoDyn's rapid growth almost like a source of nourishment and shall provide the ways and means for CytoDyn to thrive. Together, the work of David Welch and Sidley Austin imparting their strength into CytoDyn, shall deliver this molecule into the hands of the masses of people, delivering exactly where it is needed most, while protecting it from those who aspire against it.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 4

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 6

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 5

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 5

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading

Top 5 Most Recently Viewed Articles

Female Israeli Soldiers Freed in a Major Prisoner Exchange

Updated Category News Views 169

Four Israeli Soldiers Released Following Year in Captivity In a significant development, four Israeli female soldiers who had been held captive by Hamas for over a year have been released. This release is part of a broader exchange involving 200 Palestinian prisoners or detainees from Israel. Details of the Exchange The exchange took place in Gaza City and marked the...

Continue Reading
Understanding Onto Innovation Inc's Upcoming Earnings Report

Updated Category News Views 139

Anticipating Onto Innovation's Earnings Report Onto Innovation (NYSE: ONTO) is preparing to announce its quarterly earnings soon, generating buzz among investors. This overview provides critical insights into what stakeholders should keep an eye on as the release approaches. Analyst Earnings Predictions Analysts have projected that Onto Innovation will post an earnings...

Continue Reading
Dive into the Thrills of Kansas City's Haunted Attractions

Updated Category News Views 410

Kansas City's Historic Haunts Begin Their Thrilling Season The renowned haunted attractions in Kansas City's Historic West Bottoms District are set to amaze haunt enthusiasts once again. This year marks the 51st season of these beloved fright fests, opening their gates to thrill-seekers eager for spine-chilling experiences. The attractions—Beast, Edge of Hell, and...

Continue Reading
Economists Discuss Impact of Trump's Proposed Tariff Checks

Updated Category News Views 276

Proposed Tariff Checks and Economic Concerns The potential introduction of tariff-revenue checks proposed by President Donald Trump has sparked considerable debate among economists. These checks, which might amount to between $1,000 and $2,000, are seen as a potential catalyst for increased consumer spending. This spending surge could lead to heightened inflation, a...

Continue Reading
Conduit Pharmaceuticals Restructures Debt for Future Growth

Updated Category News Views 161

Conduit Pharmaceuticals Restructures Financial Obligations Conduit Pharmaceuticals Inc. has recently made significant strides in reshaping its financial landscape. By implementing a successful debt restructuring initiative, it aims to enhance its balance sheet and optimize liquidity, setting a solid foundation for future growth. The company has successfully negotiated...

Continue Reading